share_log

Imeik Technology Development Co.,Ltd. (SZSE:300896) Shares Could Be 26% Below Their Intrinsic Value Estimate

Imeikテクノロジー開発株式会社(SZSE: 300896)の株価は、内在価値の見積もりから26%下回る可能性があります。

Simply Wall St ·  02/13 17:44

Key Insights

  • Using the 2 Stage Free Cash Flow to Equity, Imeik Technology DevelopmentLtd fair value estimate is CN¥430
  • Current share price of CN¥318 suggests Imeik Technology DevelopmentLtd is potentially 26% undervalued
  • The CN¥457 analyst price target for 300896 is 6.3% more than our estimate of fair value

In this article we are going to estimate the intrinsic value of Imeik Technology Development Co.,Ltd. (SZSE:300896) by taking the expected future cash flows and discounting them to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.

Is Imeik Technology DevelopmentLtd Fairly Valued?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) estimate

2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Levered FCF (CN¥, Millions) CN¥2.38b CN¥2.93b CN¥3.58b CN¥4.07b CN¥4.50b CN¥4.87b CN¥5.19b CN¥5.48b CN¥5.74b CN¥5.98b
Growth Rate Estimate Source Analyst x2 Analyst x2 Analyst x1 Est @ 13.77% Est @ 10.52% Est @ 8.25% Est @ 6.65% Est @ 5.54% Est @ 4.76% Est @ 4.21%
Present Value (CN¥, Millions) Discounted @ 7.6% CN¥2.2k CN¥2.5k CN¥2.9k CN¥3.0k CN¥3.1k CN¥3.1k CN¥3.1k CN¥3.1k CN¥3.0k CN¥2.9k

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CN¥29b

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We discount the terminal cash flows to today's value at a cost of equity of 7.6%.

Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = CN¥6.0b× (1 + 2.9%) ÷ (7.6%– 2.9%) = CN¥133b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CN¥133b÷ ( 1 + 7.6%)10= CN¥64b

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is CN¥93b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of CN¥318, the company appears a touch undervalued at a 26% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

dcf
SZSE:300896 Discounted Cash Flow February 13th 2024

Important Assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Imeik Technology DevelopmentLtd as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.6%, which is based on a levered beta of 0.825. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Imeik Technology DevelopmentLtd

Strength
  • Earnings growth over the past year exceeded the industry.
  • Currently debt free.
  • Dividends are covered by earnings and cash flows.
  • Dividend information for 300896.
Weakness
  • Earnings growth over the past year is below its 5-year average.
  • Dividend is low compared to the top 25% of dividend payers in the Biotechs market.
  • What are analysts forecasting for 300896?
Opportunity
  • Annual earnings are forecast to grow faster than the Chinese market.
  • Trading below our estimate of fair value by more than 20%.
Threat
  • No apparent threats visible for 300896.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. What is the reason for the share price sitting below the intrinsic value? For Imeik Technology DevelopmentLtd, there are three fundamental items you should further research:

  1. Risks: Every company has them, and we've spotted 1 warning sign for Imeik Technology DevelopmentLtd you should know about.
  2. Future Earnings: How does 300896's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SZSE every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする